A. Bateman

发表

Short- and Long-Term Quality of Life and Bowel Function in Patients With MRI-Defined, High-Risk, Locally Advanced Rectal Cancer Treated With an Intensified Neoadjuvant Strategy in the Randomized Phase 2 EXPERT-C Trial.

T. Hickish, D. Tait, J. Tabernero, 2015, International journal of radiation oncology, biology, physics.

NEOSCOPE: a randomised Phase II study of induction chemotherapy followed by either oxaliplatin/capecitabine or paclitaxel/carboplatin based chemoradiation as pre-operative regimen for resectable oesophageal adenocarcinoma

H. Grabsch, C. Hurt, Ricky A. Sharma, 2015, BMC Cancer.

Systemic neoadjuvant chemotherapy in modern pancreatic cancer treatment: a systematic review and meta-analysis.

P. Pucher, J. Primrose, T. Armstrong, 2019, Annals of the Royal College of Surgeons of England.

Relationship Between Baseline Rectal Tumor Length and Magnetic Resonance Tumor Regression Grade Response to Chemoradiotherapy: A Subanalysis of the TRIGGER Feasibility Study

R. Thomas, I. Nagtegaal, D. Tait, 2022, Annals of Surgical Oncology.

NEOSCOPE: A randomised phase II study of induction chemotherapy followed by oxaliplatin/capecitabine or carboplatin/paclitaxel based pre-operative chemoradiation for resectable oesophageal adenocarcinoma

H. Grabsch, C. Hurt, Ricky A. Sharma, 2017, European journal of cancer.

Targeting Carcinoembryonic Antigen with DNA Vaccination: On-Target Adverse Events Link with Immunologic and Clinical Outcomes

S. Halford, U. Şahin, D. Jodrell, 2016, Clinical Cancer Research.

Targeting Carcinoembryonic Antigen with DNA Vaccination: On-Target Adverse Events Link with Immunological and Clinical Outcomes Running Title: Anti-CEA DNA Fusion Vaccination

S. Halford, U. Şahin, D. Jodrell, 2016 .

Oxaliplatin/capecitabine or carboplatin/paclitaxel-based preoperative chemoradiation for resectable oesophageal adenocarcinoma (NeoSCOPE): Long-term results of a randomised controlled trial

H. Grabsch, Ricky A. Sharma, T. Crosby, 2021, European journal of cancer.

Induction oxaliplatin capecitabine followed by switch to carboplatin-paclitaxel based RT versus continuing oxaliplatin capecitabine RT in operable esophageal adenocarcinoma: Survival analysis of the randomized phase II neoscope trial.

H. Grabsch, C. Hurt, Ricky A. Sharma, 2020 .

Th1 and Th17 lymphocytes expressing CD161 are implicated in giant cell arteritis and polymyalgia rheumatica pathogenesis.

B. Bonnotte, P. Manckoundia, L. Mouthon, 2012, Arthritis and rheumatism.

First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials

V. Gebski, P. Gibbs, F. Lammert, 2017, The Lancet. Oncology.

Use of a non-endoscopic immunocytological device (Cytosponge™) for post chemoradiotherapy surveillance in patients with oesophageal cancer in the UK (CYTOFLOC): A multicentre feasibility study

R. Harman, R. Fitzgerald, T. Crosby, 2022, EClinicalMedicine.

Feasibility of preoperative chemotherapy for locally advanced, operable colon cancer: the pilot phase of a randomised controlled trial

Jacob G. Scott, H. J. Pearson, C. Fuller, 2012 .

Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed non-small-cell lung cancer : the prospective Streamline L trial

Steve Halligan, Vicky Goh, William Ricketts, 2019 .

Radiotherapy and olaparib in combination for carcinoma of the oesophagus: A phase I study

A. Jackson, A. Bateman, H. Sheikh, 2023, Clinical and translational radiation oncology.

Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed colorectal cancer: the prospective Streamline C trial

Steve Halligan, Vicky Goh, William Ricketts, 2019, The lancet. Gastroenterology & hepatology.

Efficacy of early PET-CT directed switch to carboplatin and paclitaxel based definitive chemoradiotherapy in patients with oesophageal cancer who have a poor early response to induction cisplatin and capecitabine in the UK: a multi-centre randomised controlled phase II trial

E. Spezi, K. Bradley, T. Crosby, 2023, EClinicalMedicine.

Finding the needle in the haystack: the diagnostic accuracy of the faecal immunochemical test for colorectal cancer in younger symptomatic patients

P. Ziprin, Usman Khurram Khan, J. Ramage, 2021, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

Outcomes and survival following neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the esophagus: Inverse propensity score weighted analysis.

P. Pucher, J. Byrne, A. Jackson, 2020, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed non-small-cell lung cancer: the prospective Streamline L trial

A. Bhowmik, N. Strickland, V. Goh, 2019, The Lancet. Respiratory medicine.

Neoadjuvant chemoradiotherapy for resectable oesophageal and gastro-oesophageal junction cancer--do we need another randomised trial?

A. Maraveyas, A. Bateman, M. Hingorani, 2011, Clinical oncology (Royal College of Radiologists (Great Britain)).

Finding the needle in the haystack: the diagnostic accuracy of the faecal immunochemical test for colorectal cancer in younger symptomatic patients

P. Ziprin, Usman Khurram Khan, J. Ramage, 2021, Colorectal Disease.